Project Grant R01NR022275
Award Date 8/5/26
Completion Date 5/31/31
Dollars Obligated $837K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Chestnut Hill, Newton, MA, USA
Similar Awards
- The National Institute of Nursing Research awarded University of Massachusetts Medical School $7,345,938 on April 16, 2026, under the Nursing Research program (CFDA 93.361) to conduct a multi-state longitudinal study examining the effectiveness of school-based health centers to improve pediatric asthma care and advance health equity. The study will compare asthma outcomes and guideline-based care delivery in school-based health centers against traditional community health centers, focusing on...
- The National Institute of Nursing Research awarded the University of South Florida $714,413 on August 5, 2026, under the Nursing Research program (CFDA 93.361) to conduct a randomized controlled trial evaluating HERBEAT, a mobile health intervention designed to improve secondary prevention outcomes for women with coronary heart disease. The project addresses low participation and completion rates in center-based cardiac rehabilitation among women by testing HERBEAT's capacity to deliver...
- The National Heart Lung and Blood Institute awarded The Johns Hopkins University $1,090,344 on June 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct a mechanistic randomized controlled trial of the Heart Failure Resilience Intervention for Caregivers (HEROIC). The trial tests HEROIC mechanisms of action for approximately 250 family caregivers of persons with advanced heart failure and the patients they care for. HEROIC is a theory- and evidence-based...
- The National Heart, Lung, and Blood Institute awarded Brigham & Women's Hospital Inc. $908,994 on September 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to test implementation strategies for electronic health record-based interventions to improve hypertension control in primary care settings. The project builds on the recipient's prior NIH-funded REDUCE-BP trial, which enrolled 49,210 patients and 560 primary care providers and demonstrated that multi-component...
- The National Heart, Lung, and Blood Institute awarded Massachusetts General Hospital (The General Hospital Corporation) $185,196 on January 7, 2027 under the Cardiovascular Diseases Research program (CFDA 93.837). The award funds a pilot multi-center cohort study examining patient and caregiver burden in chronic limb-threatening ischemia (CLTI). Aim 1 will assess how caregiver support relates to patient outcomes including quality of life, amputation, readmission, and mortality, collecting...
- The National Institute of Nursing Research awarded The Regents of the University of California, San Francisco $836,590 on June 23, 2026, under the Nursing Research program (CFDA 93.361) to support research on the long-term impacts and mechanisms of financial programming on mental health of young adults. The project extends the BEEM Study, a randomized wait-list-controlled trial examining the impact of economic intervention—including cash payments and opt-in financial mentoring—on physical,...
- The National Cancer Institute awarded The General Hospital Corporation (Massachusetts General Hospital) $604,347 under the Cancer Treatment Research program (CFDA 93.395) on July 7, 2026, to conduct a multi-site randomized controlled trial of BREEZE+, a brief behavioral intervention for dyspnea management in patients with advanced lung cancer. BREEZE+ combines two nurse-led intervention sessions, a nurse-led booster session, and a digital health app designed to reinforce dyspnea management...
- The National Institute of Nursing Research awarded Brigham & Women's Hospital Inc. $492,250 on July 22, 2026, under the Nursing Research program (CFDA 93.361) to investigate ultra-processed foods as a modifiable risk factor for respiratory exacerbations. The research combines artificial intelligence methodologies to quantify food processing with deep clinical and molecular phenotypes from the COPDGene longitudinal cohort study. The work addresses how variability in food processing across...
- The Department of Health and Human Services National Institutes of Health Office of the Director awarded Beth Israel Deaconess Medical Center, Inc. (BIDMC) $637,845 on June 19, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213). The award funds a remote, randomized controlled study assessing the efficacy of mindfulness apps for people with depression using precision medicine methodology. The research compares participants randomized to...
- The National Institute of Nursing Research awarded the University of Maryland, Baltimore $744,172 on July 20, 2026, under the Nursing Research program (CFDA 93.361) to implement the Worksite Heart Health Improvement Project plus Function Focused Care (WHHIP+FFC) intervention, which combines physical activity promotion for assisted living facility staff with function-focused care training that embeds activity engagement into routine resident care interactions. The intervention addresses sedentary...